Adolescents in Africa are at high risk for HIV infection, other sexually transmitted infections (STIs) and bacterial vaginosis (BV). Since behavior and burden of STIs/BV may influence HIV risk, behavioral risk factors and prevalence of STIs/BV were compared in HIV-seronegative adolescent females (n = 298; 16–22 years) from two South African communities (Soweto and Cape Town). STIs (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, herpes simplex virus (HSV)-1, HSV-2, Treponema pallidum, and Haemophilus ducreyi) were detected by multiplex polymerase chain reaction, human papillomavirus (HPV) by Roche Linear Array, and BV by Nugent scoring. Rates of BV (Nugent ≥7; 46.6%) and HPV (66.8%) were high in both communities. Prevalence of C. trachomatis and N. gonorrhoeae were >2-fold higher in Cape Town than Soweto (Chlamydia: 42% [62/149] versus 18% [26/148], p < 0.0001; gonorrhoea 11% [17/149] versus 5% [7/148], p = 0.05). Only 24% of adolescents with vaginal discharge-causing STIs or BV were symptomatic. In South African adolescents, clinical symptoms compatible with vaginal discharge syndrome had a sensitivity of 23% and specificity of 85% for the diagnosis of discharge-causing STI or BV. In a region with high HIV prevalence and incidence, >70% of young women with treatable conditions that could enhance HIV risk would have been missed because they lacked symptoms associated with syndromic management.
BraxtonJCareyDDavisDet al.Centers for disease control and prevention. Sexually Transmitted Disease Surveillance 2014.
Atlanta:
U.S. Department of Health and Human Services, 2015.
3.
BanaABhatVGGodlwanaXet al.Knowledge, attitudes and behaviours of adolescents in relation to STIs, pregnancy, contraceptive utilization and substance abuse in the Mhlakulo region, Eastern Cape.S Afr Fam Pract2010;
52: 154–158.
4.
Lince-DerocheNHargeyAHoltKet al.
Accessing sexual and reproductive health information and services: a mixed methods study of young women's needs and experiences in Soweto, South Africa. Afr J Reprod Health2015;
19: 73–81.
5.
EllenJMBrownBChungSet al.
Impact of sexual networks on risk for gonorrhea and chlamydia among low-income urban African American adolescents. J Pediatr2005;
146: 518–522.
6.
BearingerLHSievingREFergusonJet al.
Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential. Lancet2007;
369: 1220–1231.
7.
Word Health Organization. Sexually Transmitted Infections (STIs). The importance of a renewed commitment to STI prevention and control in achieving sexual and reproductive health, http://apps.who.int/iris/bitstream/10665/82207/1/WHO_RHR_13.02_eng.pdf (2013, accessed 12 January 2016).
8.
ShisanaORehleTSimbayiLCet al. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012.
Cape Town:
HSRC Press, 2014.
9.
LagaMManokaAKivuvuMet al.
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS1993;
7: 95–102.
10.
MaseseLBaetenJMRichardsonBet al.
Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012. AIDS2015;
29: 1077–1085.
11.
Napierala MavedzengeS andWeissHA.Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS2009;
23: 611–620.
12.
GalvinS andCohenM.The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol2004;
2: 33–42.
13.
LewisDA.HIV/sexually transmitted infection epidemiology, management and control in the IUSTI Africa region: focus on sub-Saharan Africa. Sex Transm Infect2011;
87: ii10–ii13.
14.
McClellandRLavreysLKatingimaCet al.
Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis2005;
191: 333–338.
15.
MlisanaKNaickerNWernerLet al.
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis2012;
206: 6–14.
16.
MalhotraMSoodSMukherjeeAet al.
Genital Chlamydia trachomatis: an update. Indian J Med Res2013;
138: 303–316.
17.
MassonLMlisanaKLittleFet al.Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.Sex Transm Infect2014;
90: 580–587.
18.
GuenthnerPSecorW andDezzuttiC.Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun2005;
73: 4155.
19.
McGowinCLAnnanRSQuayleAJet al.
Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun2012;
80: 3842–3849.
20.
MuluWYimerMZenebeYet al.
Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot Referral Hospital, Ethiopia: a cross sectional study. BMC Womens Health2015;
15: 42.
21.
AtashiliJPooleCNdumbePMet al.
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS2008;
22: 1493–1501.
22.
HaggertyCLTottenPATangGet al.Identification of novel microbes associated with pelvic inflammatory disease and infertility.Sex Transm Infect2016;
92: 441–446.
23.
NelsonDBHanlonANachamkinIet al.
Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatr Perinat Epidemiol2014;
28: 88–96.
24.
ClarkPKurtzerT andDuffP.Role of bacterial vaginosis in peripartum infections. Infect Dis Obstet Gynecol1994;
2: 179–183.
25.
BautistaCTWurapaESaterenWBet al.
Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res2016;
3: 4.
MassonLPassmoreJALiebenbergLJet al.
Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis2015;
61: 260–269.
28.
KlattNRCheuRBirseKet al.Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science2017;
356: 938–945.
29.
GrodsteinFGoldmanMB andCramerDW.Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol1993;
137: 577–584.
30.
National Health Research Ethics Council (NHREC) of South Africa. Payment of trial participants in South Africa: ethical considerations for Research Ethics Committees (RECs). Pretoria, South Africa: NHREC, 2012.
31.
LewisDMüllerESteeleLet al.
Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa. Sex Transm Dis2012;
39: 880–885.
32.
KranzerKvan SchaikNKarmueUet al.
High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. PLoS One2011;
6: e25244.
33.
CoatesTJKulichMCelentanoDet al.
Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. Lancet Glob Heal2014;
2: 267–277.
34.
JohnsonLDorringtonRBradshawDet al.
The role of sexually transmitted infections in the evolution of the South African HIV epidemic. Trop Med Int Health2012;
17: 161–168.
35.
HaggertyCGottliebSTaylorBet al.
Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis2010;
201: S134–S155.
TorroneEPappJ andWeinstockH.Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years – United States. 2007–2012 MMWR. 2014;
63: 834–838.
38.
SwedbergJSteinerJFDeissFet al.
Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;
254: 1046–1049.
